IP Library Granted Patent US 6,841,150
Granted Patent B2
US 6,841,150 · App. 10/125,106 · Granted Jan 11, 2005

Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,841,150
App. No.
10/125,106
Granted
Jan 11, 2005
Kind
B2
Abstract

Methods and compositions for directing adipose-derived stromal cells cultivated in vitro to differentiate into cells of the chondrocyte lineage are disclosed. The invention further provides a variety of chondroinductive agents which can be used singly or in combination with other nutrient components to induce chondrogenesis in adipose-derived stromal cells either in cultivating monolayers or in a biocompatible lattice or matrix in a three-dimensional configuration. Use of the differentiated chondrocytes for the therapeutic treatment of a number of human conditions and diseases including repair of cartilage in vivo is disclosed.

Claims (8)

1. A method of treating a cartilage defect in a mammal, the method comprising:

a) differentiating an isolated human adipose tissue derived stromal cell into a chondrocytic cell; and

b) administering said chondrocytic cell to a cartilage defect area in a mammal.

2. The method of claim 1 , wherein said cell further comprises a biocompatible matrix.

3. The method of claim 2 , wherein said biocompatible matrix is selected from the group consisting of calcium alginate, agarose, fibrin, an collagen.

4. The method of claim 1 , wherein said adipose tissue derived stromal cell is genetically modified.

5. The method of claim 1 , wherein said mammal is a human.

6. The method of claim 1 , wherein following administration of said chondrocytic cell to a cartilage defect area in a mammal, the cell further differentiates in situ in said human.

Assignments (7)
MERGER Recorded Sep 7, 2016
From: ARTECEL, INC.
To: COGNATE BIOSERVICES, INC.
Reel/Frame 039662/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2016
From: ARTECEL SCIENCES, INC.
To: ARTECEL, INC
Reel/Frame 038397/0681 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2016
From: ZEN-BIO, INC.
To: ARTECEL SCIENCES, INC.
Reel/Frame 038248/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2016
From: HALVORSEN, YUAN-DI C.; WILKISON, WILLIAM O.; GIMBLE, JEFFREY M.
To: ZEN-BIO, INC.
Reel/Frame 038248/0070 →
LIEN Recorded Apr 30, 2009
From: ARTECEL, INC.; COGNATE BIOSERVICES, INC.; THERADIGM, INC.
To: SEED INTELLECTUAL PROPERTY LAW GROUP PLLC
Reel/Frame 022619/0065 →
SECURITY INTEREST Recorded Nov 4, 2005
From: ARTECEL SCIENCES, INC.
To: ARTECEL, INC.
Reel/Frame 017178/0895 →
SECURITY AGREEMENT Recorded May 8, 2003
From: ARTECEL INC
To: ARTECEL SCIENCES, INC.
Reel/Frame 014039/0392 →